| JNJJOHNSON & JOHNSON | 2,985,476 | $729.8M |
| LLYELI LILLY & Co | 686,584 | $631.5M |
| MRKMerck & Co., Inc. | 3,799,379 | $457.0M |
| ABTABBOTT LABORATORIES | 3,419,348 | $351.1M |
| ABBVAbbVie Inc. | 1,612,838 | $350.8M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,294,924 | $350.4M |
| REGNREGENERON PHARMACEUTICALS, INC. | 329,018 | $254.2M |
| GILDGILEAD SCIENCES, INC. | 1,544,223 | $215.2M |
| UTHRUNITED THERAPEUTICS Corp | 343,659 | $203.8M |
| GMOptec International, Inc. | 2,426,480 | $180.8M |
| CORCencora Inc. | 525,497 | $165.1M |
| IDXXIDEXX LABORATORIES INC /DE | 263,051 | $147.8M |
| INCYIncyte Corp. | 1,520,486 | $143.1M |
| BIIBBIOGEN INC. | 518,694 | $95.1M |
| PFEPFIZER INC | 3,261,941 | $91.6M |
| BMYBRISTOL MYERS SQUIBB CO | 1,483,832 | $90.0M |
| HALOHALOZYME THERAPEUTICS, INC. | 1,121,200 | $72.5M |
| ELVElevance Health Inc. | 243,559 | $71.3M |
| ZTSZoetis Inc. | 535,446 | $63.3M |
| MEDPMedpace Holdings Inc. | 130,249 | $62.5M |
| QGENQIAGEN N.V. | 1,415,876 | $56.7M |
| BMRNBIOMARIN PHARMACEUTICAL INC | 945,603 | $53.4M |
| CAHCardinal Health Inc. | 202,130 | $42.7M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 50,917 | $22.7M |
| AMGNAMGEN INC | 56,394 | $19.8M |
| MCKMcKesson Corporation | 14,977 | $13.0M |
| NBIXNEUROCRINE BIOSCIENCES INC | 93,622 | $12.3M |
| RPRXRoyalty Pharma plc | 218,031 | $10.5M |
| CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 40,377 | $7.0M |
| WSTWest Pharmaceutical Services Inc. | 5,753 | $1.4M |
| DVADaVita Inc. | 9,200 | $1.4M |
| VTRSViatris Inc | 69,909 | $944K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 1,988 | $658K |
| INSMINSMED Inc | 3,209 | $525K |
| LEGNLegend Biotech Corp | 16,216 | $293K |
| RGENREPLIGEN CORP | 2,300 | $271K |
| ZBHZimmer Biomet Holdings Inc. | 2,983 | $270K |
| RVMDREVOLUTION MEDICINES, INC. | 2,182 | $212K |